Alibaba’s shares on the Hong Kong stock exchange rose today by more than 15%, marking their largest one-day gain since March of this year. This sharp increase is primarily a market reaction to the company’s strategic move into the design and production of its own AI chips. This news coincided with the publication of quarterly results, but it was the expansion into the semiconductor market that investors viewed as a potential game changer for Alibaba’s long-term growth.
The company unveiled its own chip designed for artificial intelligence tasks, which has already been physically produced in a local Chinese factory. This means that Alibaba is not only expanding its technological activities beyond traditional e-commerce and cloud services but is also actively joining the race for independence from Western suppliers, led by NVIDIA. Although Alibaba’s new chip is currently focused mainly on running pre-trained AI models, it was designed to be compatible with the popular software previously used with NVIDIA’s hardware. This compatibility can make its practical deployment much easier and more cost-effective.
The market interprets this move as a clear signal that Alibaba intends not only to use AI as a business tool but also to build its own technological base in hardware. This aligns with a broader trend in China, where more companies are striving to create alternatives to American solutions in response to ongoing export restrictions.
Chinese chips still face certain challenges, such as lower performance, stability issues, and technological production limitations. Despite these difficulties, Alibaba’s start of chip production is a significant step toward building long-term technological independence. Government support—including an $8.4 billion fund for the development of AI and semiconductors—further strengthens the foundation for this strategic direction.
From an investor’s perspective, Alibaba’s entry into the chip market is not only a response to global tensions in the technology sector but also a sign that the company does not intend to limit itself to software and cloud services. Instead, it aims to control the entire AI ecosystem, from hardware to software. Today’s surge in stock prices confirms that the market values this ambition.
Netflix disappoints with Q3 2025 results. Shares drop over 5% in after-hours trading!
Daily summary: Markets on Hold Ahead of Netflix Earnings
OpenAI threatens Google’s dominance. Alphabet shares under pressure.
UnitedHealth Invests in AI. Stock Price on the Rise!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
